Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
暂无分享,去创建一个
G. Fonarow | K. Maki | M. Davidson | M. Dicklin | B. Ansell | M. Bell
[1] J. Mckenney,et al. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. , 2005, The American journal of cardiology.
[2] Thomas Mills,et al. National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines , 2005, Circulation.
[3] K. Watson,et al. Opportunity for Intervention to Achieve American Heart Association Guidelines for Optimal Lipid Levels in High-Risk Women in a Managed Care Setting , 2005, Circulation.
[4] L. Mosca,et al. Tracking Women’s Awareness of Heart Disease: An American Heart Association National Study , 2004, Circulation.
[5] S. Grundy,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[6] Constance K Haan,et al. Evidence-based guidelines for cardiovascular disease prevention in women. , 2004, Circulation.
[7] Mark A Hlatky,et al. Differences in Medical Care and Disease Outcomes Among Black and White Women With Heart Disease , 2003, Circulation.
[8] G. Mensah,et al. Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults: Findings From the National Health and Nutrition Examination Survey, 1999 to 2000 , 2003, Circulation.
[9] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[10] T. Pearson,et al. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.
[11] J. Manson,et al. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. , 1997, Circulation.